New Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control (CDSCO) has granted ...

President and CEO: Jake Allen - Goldman Sachs: Sung Ji Nam - Scotiabank: Kyle Mikson - Canaccord Genuity: Puneet Souda - ...

A slow launch for Alzheimer's medicine Leqembi, a lackluster pipeline and a challenging drug launch environment are just a ...

Imagine having so much to say but feeling held back by the words themselves—speech disorders are more common than you might ...

Fatigue related to multiple sclerosis (MS) was significantly reduced following 12 weeks of treatment with cognitive ...

Two enzymes in brain cells are responsible for mediating the toxic effects of certain fat molecules in multiple sclerosis, ...

Even after controlling for a person’s existing substance use and mental health disorders, there remained a 3.5-fold increased ...

Alzheimer’s Disease · Amyotrophic Lateral Sclerosis (ALS) · Autism · ADHD · Schizophrenia · Stroke · Brain Tumors · Multiple Sclerosis · Parkinson’s Disease · Epilepsy and Seizures · Dyslexia · ...

A team of researchers led by Rice University's Jacob Robinson and the University of Texas Medical Branch's Peter Kan has ...

From the company's own site, we can see this pharma brand has a diversified portfolio of therapies across multiple clinical ...

Professor Nancy Ip discusses her groundbreaking neuroscience research, focusing on neurotrophic factors and innovative ...

Researchers map the unique genetic regulation of proteins in human cerebrospinal fluid, identifying potential targets for ...